Search

Sep 3, 2024
The CEO of Tarsus shares an update on the launch of XDEMVY, and what the company is doing to reach more patients in the quarters ahead
Bobby Azamian describes how Tarsus has expanded its salesforce by 50%, and will be adding a DTC element to the launch and derive...

Jan 10, 2024
Tarsus' CEO on the launch XDEMVY and additional programs that will be reading out in 2024
Bobby Azamian provides an update on the commercial launch of XDEMY in demodex blepharitis, and discusses additional programs.